Clinical decision making in the treatment of mixed states

References

• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental health disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Publishing.
   Google Scholar
• Azorin JM, Aubrun E, Bertsch J, Reed C, Gerard S, Lukasiewicz M. 2009. Mixed states vs pure mania in the French sample of the EMBLEM study: results at baseline and 24 months – European mania in bipolar longitudinal evaluation of medication. BMC Psychiatry 9:33.
   PubMed Web of Science ®Google Scholar
• Azorin JM, Sapin C, Weiller E. 2013. Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses. J Affect Disord 145:62–69.
   PubMed Web of Science ®Google Scholar
• Backlund L, Ehnvall A, Hetta J, Isacsson G, Agren H. 2009. Identifying predictors for good lithium response – a retrospective analysis of 100 patients with bipolar disorder using a life-charting method. Eur Psychiatry 24:171–177.
   PubMed Web of Science ®Google Scholar
• Baker RW, Brown E, Akiskal HS, Calabrese JR, Ketter TA, Schuh LM, et al. 2004. Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. Br J Psychiatry 185:472–478.
   PubMed Web of Science ®Google Scholar
• Baker RW, Tohen M, Fawcett J, Risser RC, Schuh LM, Brown E, et al. 2003. Acute dysphoric mania: treatment response to olanzapine versus placebo. J Clin Psychopharmacol 23: 132–137.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Hennen J, Wilson M, Calabrese J, Chengappa R, Keck PE Jr, et al. 2003. Olanzapine versus placebo in acute mania: treatment responses in subgroups. J Clin Psychopharmacol 23:370–376.
   PubMed Web of Science ®Google Scholar
• Benabarre A, Vieta E, Colom F, Martinez A, Reinares M, Corbella B. 2001. Treatment of mixed mania with risperidone and mood stabilizers. Can J Psychiatry 46:866–867.
   PubMed Web of Science ®Google Scholar
• Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M. 2009. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. J Clin Psychiatry 70:1424–1431.
   PubMed Web of Science ®Google Scholar
• Berwaerts J, Xu H, Nuamah I, Lim P, Hough D. 2012. Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: a randomized, double- blind, dose-response study. J Affect Disord 136:e51–e60.
   PubMed Web of Science ®Google Scholar
• Born C, Bernhard B, Dittmann S, Seemüller F, Grunze H. 2009. Lamotrigine in bipolar disorder: results of a mirror-image evaluation using the NIMH Lifechart-Methodology. J Affect Disord 115:241–245.
   PubMed Web of Science ®Google Scholar
• Bottlender R, Sato T, Kleindienst N, Strauss A, Moller HJ. 2004. Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder. J Affect Disord 78:149–152.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Collins MA, McElroy SL, Calabrese JR, Swann AC, Weisler RH, et al. 2005. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo. Neuropsychopharmacology 30:1932–1939.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Swann AC, Calabrese JR, Rubenfaer LM, Wozniak PJ, Collins MA, et al. 2006. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry 67:1501–1510.
   PubMed Web of Science ®Google Scholar
• Carlson BX, Ketter TA, Sun W, Timko K, McQuade RD, Sanchez R, et al. 2012. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). Bipolar Disord 14:41–53.
   PubMed Web of Science ®Google Scholar
• Crismon L, Argo T, Bendele S, Suppes T. 2007. Texas Medication Algorithm Project Procedural Manual – Bipolar Disorder Algorithms. Texas Department of State Health Services. Available from: http://www.pbhcare.org/pubdocs/upload/documents/TIMABDman2007.pdf (accessed 18 February 2014).
   Google Scholar
• Fountoulakis KN, Kontis D, Gonda X, Siamouli M, Yatham LN. 2012. Treatment of mixed bipolar states. Int J Neuro psychopharmacol 15:1015–1026.
   PubMed Web of Science ®Google Scholar
• Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE Jr, et al. 2009. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry 166:164–172.
   PubMed Web of Science ®Google Scholar
• Ginsberg LD. 2006. Efficacy and safety of lamotrigine for adults with bipolar disorder in a private practice setting. CNS Spectr 11:376–382.
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, et al. 2009. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry 166:173–181.
   PubMed Web of Science ®Google Scholar
• Goodwin GM. 2009. Evidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for Psychopharmacology. J Psychopharmacol 23:346–388.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. 2009. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania. World J Biol Psychiatry 10:85–116.
   PubMed Web of Science ®Google Scholar
• Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA. 2009. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. J Clin Psychiatry 70:1540–1547.
   PubMed Web of Science ®Google Scholar
• Keck PE, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, et al. 2003a. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 160:1651–1658.
   PubMed Web of Science ®Google Scholar
• Keck PE, Versiani M, Potkin S, West SA, Giller E, Ice K. 2003b. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 160:741–748.
   PubMed Web of Science ®Google Scholar
• Kessing LV, Hellmund G, Andersen PK. 2012. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. J Psychopharmacol 26:644–652.
   PubMed Web of Science ®Google Scholar
• Kessing LV, Hellmund G, Geddes JR, Goodwin GM, Andersen PK. 2011. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry 199:57–63.
   PubMed Web of Science ®Google Scholar
• Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M. 2005. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 187: 229–234.
   PubMed Web of Science ®Google Scholar
• Llorca PM, Courtet P, Martin P, Abbar M, Gay C, Meynard JA, et al. 2010. Recommandations formalisées d’experts (RFE). Dépistage et prise en charge du trouble bipolaire. Encéphale 36(Suppl)4:79–102.
   Google Scholar
• Malhi GS, Adams D, Lampe L, Paton M, O’Connor N, Newton LA, et al. 2009. Clinical practice recommendations for bipolar disorder. Acta Psychiatr Scand 119(Suppl)439: 27–46.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J. 2009a. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states. Bipolar Disord 11:673–686.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J. 2009b. Asenapine versus olanzapine in acute mania: a double-blind extension study. Bipolar Disord 11:815–826.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J. 2010. Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial. J Affect Disord 122:27–38.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Tohen M, Berk M, Zhao J, Weiller E. 2013. DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data. J Affect Disord 150:378–383.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Yoon J. 2012. Efficacy of antimanic treatments in mixed states. Bipolar Disord 14(Suppl)2:22–36.
   PubMed Web of Science ®Google Scholar
• Nolen WA, Weisler RH. 2013. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double- blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144). Bipolar Disord 15:100–109.
   PubMed Web of Science ®Google Scholar
• Patkar A, Gilmer W, Pae CU, Vohringer PA, Ziffra M, Pirok E, et al. 2012. A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. PLoS One 7:e34757.
   PubMed Web of Science ®Google Scholar
• Potkin SG, Keck PE Jr, Segal S, Ice K, English P. 2005. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 25:301–310.
   PubMed Web of Science ®Google Scholar
• Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, et al. 2006. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol 20:536–546.
   PubMed Web of Science ®Google Scholar
• Stahl S, Lombardo I, Loebel A, Mandel FS. 2010. Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies. J Affect Disord 122:39–45.
   PubMed Web of Science ®Google Scholar
• Strejilevich S, Vazquez G, Garcia BG, Zaratiegui R, Vilaprino JJ, Herbst L, et al. 2010. II Consenso argentino sobre el tratamiento de los trastornos bipolares 2010. Vertex 21(Suppl II Consenso):3–55.
   PubMedGoogle Scholar
• Strejilevich SA, Martino DJ, Marengo E, Igoa A, Fassi G, Whitham EA, et al. 2011. Long-term worsening of bipolar disorder related with frequency of antidepressant exposure. Ann Clin Psychiatry 23:186–192.
   PubMed Web of Science ®Google Scholar
• Suppes T, Eudicone J, McQuade R, Pikalov A III, Carlson B. 2008. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. J Affect Disord 107:145–154.
   PubMed Web of Science ®Google Scholar
• Suppes T, Vieta E, Liu S, Brecher M, Paulsson B. 2009. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in com bination with lithium or divalproex (trial 127). Am J Psychiatry 166:476–488.
   PubMed Web of Science ®Google Scholar
• Swann AC. 2011. Diagnosis and treatment of mixed states. In: Akiskal HS, Tohen M, eds. Bipolar psychopharmacology: caring for the patient. West Sussex: Wiley-Blackwell. p. 391–410.
   Google Scholar
• Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, et al. 1997. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54: 37–42.
   PubMed Web of Science ®Google Scholar
• Swann AC, Lafer B, Perugi G, Frye MA, Bauer M, Bahk WM, et al. 2013. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry 170:31–42.
   PubMed Web of Science ®Google Scholar
• Szegedi A, Zhao J, van WA, Nations KR, Mackle M, Panagides J. 2011. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials. BMC Psychiatry 11:101.
   PubMed Web of Science ®Google Scholar
• Tavormina G. 2013. A long term clinical diagnostic-therapeutic evaluation of 30 case reports of bipolar spectrum mixed states. Psychiatr Danub 25(Suppl)2:S190–193.
   Web of Science ®Google Scholar
• Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, et al. 2006. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 163:247–256.
   PubMed Web of Science ®Google Scholar
• Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, et al. 2002. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 59:62–69.
   PubMed Web of Science ®Google Scholar
• Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, et al. 2000. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 57: 841–849.
   PubMed Web of Science ®Google Scholar
• Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, et al. 1999. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 156:702–709.
   PubMed Web of Science ®Google Scholar
• Tohen M, Sutton VK, Calabrese JR, Sachs GS, Bowden CL. 2009. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. J Affect Disord 116:43–50.
   PubMed Web of Science ®Google Scholar
• Valenti M, Pacchiarotti I, Rosa AR, Bonnin CM, Popovic D, Nivoli AM, et al. 2011. Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients. Bipolar Disord 13:145–154.
   PubMed Web of Science ®Google Scholar
• Vieta E, Herraiz M, Fernandez A, Gasto C, Benabarre A, Colom F, et al. 2001. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD). J Clin Psychiatry 62:623–630.
   PubMed Web of Science ®Google Scholar
• Vieta E, Nuamah IF, Lim P, Yuen EC, Palumbo JM, Hough DW, et al. 2010. A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder. Bipolar Disord 12:230–243.
   PubMed Web of Science ®Google Scholar
• Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M. 2008. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 109: 251–263.
   PubMed Web of Science ®Google Scholar
• Vieta E, Suppes T, Ekholm B, Udd M, Gustafsson U. 2012. Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder. J Affect Disord 142:36–44.
   PubMed Web of Science ®Google Scholar
• Vieta E, Valenti M. 2013. Mixed states in DSM-5: implications for clinical care, education, and research. J Affect Disord 148:28–36.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter TA, Keck PE, et al. A, Kalali A. 2006. Extended-release carbamazepine capsules as monotherapy in bipolar disorder: pooled results from two randomised, double-blind, placebo-controlled trials. CNS Drugs 20:219–231.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Kalali AH, Ketter TA. 2004. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 65:478–484.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA, Kalali AH. 2005. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 66:323–330.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Nolen WA, Neijber A, Hellqvist A, Paulsson B. 2011. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). J Clin Psychiatry 72:1452–1464.
   PubMed Web of Science ®Google Scholar
• Woo YS, Bahk WM, Jon DI, Chung SK, Lee SY, Ahn YM, et al. 2010. Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea. Psychiatry Clin Neurosci 64:28–37.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Binder C, Riccardelli R, Leblanc J, Connolly M, Kusumakar V. 2003. Risperidone in acute and continuation treatment of mania. Int Clin Psychopharmacol 18:227–235.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Fountoulakis KN, Rahman Z, Ammerman D, Fyans P, Marler SV, et al. 2013a. Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode. J Affect Disord 147:365–372.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. 2013b. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 15:1–44.
   PubMed Web of Science ®Google Scholar